CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on enhancing asymmetric catalysis for drug production by developing a modular chiral catalyst. This innovative approach aims to improve efficiency and selectivity in chemical synthesis, reducing costs and environmental impact in the pharmaceutical industry.
There is a continuous interest to apply homogeneous catalysis to asymmetric synthesis, which is the elective method for drugs production in pharmaceutical industry.
Asymmetric catalysis provides the cheapest synthetic route to optically active compounds with minimal number of steps and reduced use of expensive chiral substrates.
Replacing conventional methods with those involving asymmetric catalysis is then mandatory to reduce considerably energy/materials costs and the environmental impact of…
A.N. NESMEYANOV INSTITUTE OF ORGANOELEMENT COMPOUNDS OF RUSSIAN ACADEMY OF SCIENCES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
